IP Library Granted Patent US 8,318,496
Granted Patent B2
US 8,318,496 · App. 12/681,593 · Granted Nov 27, 2012

Compounds and methods for improving cellular uptake of oligomeric compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,318,496
App. No.
12/681,593
Granted
Nov 27, 2012
Kind
B2
Abstract

The present invention provides method of optimizing the efficacy and potency of antisense drugs. In certain embodiments, the invention provides assays useful for determining favorable oligonucleotide characteristics and excipeints for improved cellular uptake.

Claims (10)

1. A method comprising contacting an MHT cell in vitro with an oligomeric compound in the absence of cationic lipid and assessing cellular uptake of the oligomeric compound.

2. The method of claim 1 , wherein the method comprises a competition assay.

3. The method of claim 1 , wherein the oligomeric compound is a modified oligonucleotide.

4. The method of claim 2 , wherein the oligomeric compound is a modified oligonucleotide.

5. The method of claim 1 , wherein the oligomeric compound comprises a mixed backbone.

6. The method of claim 2 , wherein the oligomeric compound comprises a mixed backbone.

7. The method of claim 1 , wherein the oligomeric compound comprises a nucleoside comprising a 2′ modification.

8. The method of claim 2 , wherein the oligomeric compound comprises a nucleoside comprising a 2′ modification.

9. The method of claim 1 , wherein the assessing cellular uptake of the oligomeric compound comprises determining oligomeric compound activity.

10. The method of claim 2 , wherein the assessing cellular uptake of the oligomeric compound comprises determining oligomeric compound activity.

Assignments (2)
CHANGE OF NAME Recorded Jun 28, 2017
From: ISIS PHARMACEUTICALS, INC.
To: IONIS PHARMACEUTICALS, INC.
Reel/Frame 043029/0365 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2010
From: KOLLER, ERICH; BENNETT, C. FRANK
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 024742/0427 →